Medicare Enrolled
Dr. Jeffrey Lapeyrolerie, M.D.
Optician · Garfield Hts, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lapeyrolerie from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lapeyrolerie?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lapeyrolerie
Dr. Jeffrey Lapeyrolerie is an optician specialist in Garfield Hts, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lapeyrolerie performed 5,495 Medicare services across 2,719 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lapeyrolerie received a total of $13,869 from 53 pharmaceutical and/or device companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lapeyrolerie is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in OH
$13,869 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,495
Medicare services
Top 6% in OH for optician
2,719
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~275 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Leuprolide injectable, camcevi, 1 mg | 756 | $65 | $190 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
745 | $61 | $140 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
637 | $4 | $10 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
477 | $7 | $10 |
| PSA test (prostate cancer screening) | 364 | $18 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $88 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
238 | $10 | $45 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
225 | $57 | $135 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
170 | $99 | $265 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
164 | $18 | $50 |
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
164 | $0 | $1 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
143 | $91 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
125 | $37 | $80 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 123 | $129 | $410 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
94 | $8 | $20 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $133 | $390 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
82 | $25 | $55 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
69 | $167 | $420 |
| Injection, garamycin, gentamicin, up to 80 mg | 67 | $2 | $60 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
62 | $22 | $70 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
55 | $19 | $77 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $107 | $315 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
36 | $19 | $50 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
28 | $100 | $1,097 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
23 | $5 | $85 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
23 | $98 | $540 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
22 | $91 | $275 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $99 | $460 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
15 | $529 | $4,140 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $47 | $60 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
12 | $285 | $655 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
12 | $24 | $400 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
12 | $142 | $265 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
12 | $116 | $575 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
11 | $35 | $215 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
11 | $50 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
11.6% medium
87.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,869
Total received (2018-2024)
Avg $1,981/year across 7 years
Top 11% in OH for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
284
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,671 (84.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,723 (12.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$475 (3.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,041
2023
$1,734
2022
$1,292
2021
$898
2020
$2,713
2019
$2,835
2018
$1,357
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$663
COLOPLAST CORP
$658
Olympus America Inc.
$356
Blue Earth Diagnostics Limited
$284
Sumitomo Pharma America, Inc.
$202
Myriad Genetic Laboratories, Inc.
$198
Axonics, Inc.
$152
Agiliti Surgical, Inc.
$104
Astellas Pharma US Inc
$86
Tolmar, Inc.
$70
Verity Pharmaceuticals Inc.
$66
UROGEN PHARMA, INC.
$47
Bayer Healthcare Pharmaceuticals Inc.
$35
PFIZER INC.
$28
PROGENICS PHARMACEUTICALS, INC.
$20
ABBVIE INC.
$19
IMMUNITYBIO, INC.
$19
AstraZeneca Pharmaceuticals LP
$18
Janssen Biotech, Inc.
$15
Top 3 companies account for 55.1% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$2,816
Coloplast Corp
$2,163
Boston Scientific Corporation
$1,458
Astellas Pharma US Inc
$996
COLOPLAST CORP
$773
Olympus America Inc.
$492
Blue Earth Diagnostics Limited
$476
Sumitomo Pharma America, Inc.
$422
Janssen Biotech, Inc.
$398
Myriad Genetic Laboratories, Inc.
$382
AstraZeneca Pharmaceuticals LP
$366
Medtronic, Inc.
$225
Myovant Sciences Inc.
$206
Axonics, Inc.
$186
PFIZER INC.
$148
Axonics Modulation Technologies, Inc.
$147
Augmenix, Inc.
$146
Becton, Dickinson and Company
$143
ACELL, INC.
$125
Palette Life Sciences, Inc.
$124
Accord Healthcare, Inc.
$117
PROCEPT BioRobotics Corporation
$112
Endo Pharmaceuticals Inc.
$112
Agiliti Surgical, Inc.
$104
AbbVie Inc.
$100
UroGen Pharma, Inc.
$96
Bayer HealthCare Pharmaceuticals Inc.
$86
NxThera, Inc.
$85
UROGEN PHARMA, INC.
$73
Tolmar, Inc.
$70
MEDIVATION FIELD SOLUTIONS LLC
$67
Verity Pharmaceuticals Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$66
Ethicon US, LLC
$48
Antares Pharma, Inc.
$42
Renovia Inc
$41
Zyla Life Sciences, Inc.
$40
Merck Sharp & Dohme LLC
$38
Medline Industries, Inc.
$29
UROVANT SCIENCES INC
$27
DENTSPLY IH AB
$27
Progenics Pharmaceuticals, Inc.
$26
Stryker Corporation
$23
Amgen Inc.
$23
ConvaTec Inc.
$23
PROGENICS PHARMACEUTICALS, INC.
$20
ABBVIE INC.
$19
IMMUNITYBIO, INC.
$19
Sun Pharmaceutical Industries Inc.
$19
Foundation Medicine, Inc.
$17
Mission Pharmacal Company
$15
Ferring Pharmaceuticals Inc.
$14
DENTSPLY IH Inc.
$12
Top 3 companies account for 46.4% of all-time payments
Associated products mentioned in payments ›
1688 · ALTIS · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · AXIS · Altis · Aquoral · Axonics r-SNM System · Axumin · Bulkamid · CAMCEVI · Coloplast TFL Drive · ELIGARD · ERASE CAUTI Total Trays · ERLEADA · Echelon Flex · Erleada · FEMALE INCONTINENCE · FIRMAGON · GELFOAM · GEMTESA · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENTLECATH · Genesis · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · PELVIC FLOOR REPAIR · PENILE & TESTICULAR RECONSTRUCTN · POSLUMA · PRECISETUMOR · PROGEL · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · Rezum · SPEEDICATH · SPRIX · SURGICEL Family of Absorbable Hemostats · SUSPEND · Saffron · Sonablate HIFU · SpaceOAR · THROMBIN-JMI · TITAN · Titan · Trelstar · VESICARE · Virtue · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System · leva Pelvic Floor Trainer
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
318
Per 100K population
25.5
County median income
$62,823
Nearest hospital
MARYMOUNT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lapeyrolerie is a mixed practice specialist, with above-average Medicare volume (top 6% in OH), with low-engagement industry engagement in the top 11% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lapeyrolerie experienced with leuprolide injectable, camcevi, 1 mg?
Based on Medicare claims data, Dr. Lapeyrolerie performed 756 leuprolide injectable, camcevi, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lapeyrolerie receive payments from pharmaceutical companies?
Yes. Dr. Lapeyrolerie received a total of $13,869 from 53 companies across 284 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lapeyrolerie's costs compare to other opticians in Garfield Hts?
Dr. Lapeyrolerie's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lapeyrolerie) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Garfield Hts
Browse opticians in Garfield Hts ranked by procedure volume and transparency data.
Highest volume
Top Opticians in OH
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in OH
Which OH opticians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology